Abstract
The effects of methotrexate (MTX) and 2,4-diamino-5-(3′,4′-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells were compared. Two sub-lines of cells were used, one sensitive to methotrexate and the other resistant. In addition, the inhibitory effects of BW50197 against dihydrofolate reductase (DHFR) extracted from the MTX resistant cells were compared with those of MTX and pyrimethamine. It was found that although BW50197 was a less effective inhibitor of DHFR than MTX, it was superior to MTX at high concentrations in killing MTX resistant cells, and this superiority increased with the time of exposure to the drugs. These findings suggest that (a) when antifolate compounds are screened for antitumour activity it is insufficient simply to assess them on the basis of their ability to inhibit DHFR and (b) BW50197 should be given clinically so as to achieve the highest possible tissue concentration for the longest possible time consistent with the safety of the patient.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chu M. Y., Fischer G. A. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). Biochem Pharmacol. 1968 May;17(5):753–767. doi: 10.1016/0006-2952(68)90012-9. [DOI] [PubMed] [Google Scholar]
- Djerassi I., Rominger C. J., Kim J. S., Turchi J., Suvansri U., Hughes D. Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer. 1972 Jul;30(1):22–30. doi: 10.1002/1097-0142(197207)30:1<22::aid-cncr2820300105>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
- Geils G. F., Scott C. W., Jr, Baugh C. M., Butterworth Treatment of meningeal leukemia with pyrimethamine. Blood. 1971 Aug;38(2):131–137. [PubMed] [Google Scholar]
- Goldie J. H., Price L. A., Harrap K. R. Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. Eur J Cancer. 1972 Aug;8(4):409–414. doi: 10.1016/0014-2964(72)90125-9. [DOI] [PubMed] [Google Scholar]
- Harrap K. R., Hill B. T., Furness M. E., Hart L. I. Sites of action of amethopterin: intrinsic and acquired drug resistance. Ann N Y Acad Sci. 1971 Nov 30;186:312–324. doi: 10.1111/j.1749-6632.1971.tb46986.x. [DOI] [PubMed] [Google Scholar]
- Kessel D., Hall T. C., Roberts D. Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response. Cancer Res. 1968 Mar;28(3):564–570. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- MATHEWS C. K., HUENNEKENS F. M. FURTHER STUDIES ON DIHYDROFOLIC REDUCTASE. J Biol Chem. 1963 Oct;238:3436–3442. [PubMed] [Google Scholar]
- MURPHY M. L., ELLISON R. R., KARNOFSKY D. A., BURCHENAL J. H. Clinical effects of the dichloro and monochlorophenyl analogues of diamino pyrimidine: antagonists of folic acid. J Clin Invest. 1954 Oct;33(10):1388–1396. doi: 10.1172/JCI103016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SUGIURA K. Effect of various compounds on the Ehrlich ascites carcinoma. Cancer Res. 1953 Jun;13(6):431–441. [PubMed] [Google Scholar]
- WOOD R. C., FERONE R., HITCHINGS G. H. The relationship of cellular permeability to the degree of inhibition by amethopterin and pyrimethamine in several species of bacteria. Biochem Pharmacol. 1961 May;6:113–124. doi: 10.1016/0006-2952(61)90155-1. [DOI] [PubMed] [Google Scholar]